Variant report
Variant | esv18414 |
---|---|
Chromosome Location | chr8:3566776-3568330 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | GABPA | chr8:3567126-3567248 | HepG2 | liver: | n/a | n/a |
2 | MAFK | chr8:3566987-3567157 | HepG2 | liver: | n/a | n/a |
3 | MAFK | chr8:3566991-3567197 | HepG2 | liver: | n/a | n/a |
4 | POLR2A | chr8:3567361-3567449 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CSMD1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6981921 | chr8:3566780-3566781 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs6981931 | chr8:3566791-3566792 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs558960718 | chr8:3566793-3566794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs71521887 | chr8:3566802-3566803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs375202752 | chr8:3566804-3566805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577863035 | chr8:3566815-3566816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545023560 | chr8:3566817-3566818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563453683 | chr8:3566822-3566823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369845752 | chr8:3566834-3566835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187761500 | chr8:3566840-3566841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs6996329 | chr8:3566852-3566853 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs561344322 | chr8:3566853-3566854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs528630028 | chr8:3566892-3566893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547006145 | chr8:3566900-3566901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs71521888 | chr8:3566911-3566912 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375443337 | chr8:3566930-3566931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144605253 | chr8:3566931-3566932 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561897512 | chr8:3566939-3566940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190844340 | chr8:3566945-3566946 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569400059 | chr8:3566974-3566975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs536471264 | chr8:3566993-3566994 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs183896316 | chr8:3566994-3566995 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs74839656 | chr8:3567001-3567002 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs79249519 | chr8:3567010-3567011 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs75484485 | chr8:3567016-3567017 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs555795584 | chr8:3567020-3567021 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs531029009 | chr8:3567035-3567036 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs188800727 | chr8:3567076-3567077 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs545252089 | chr8:3567085-3567086 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs143792676 | chr8:3567104-3567105 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs112315858 | chr8:3567106-3567107 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs550800092 | chr8:3567107-3567108 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs9285037 | chr8:3567109-3567110 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs551713247 | chr8:3567120-3567121 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs537321970 | chr8:3567123-3567124 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs547118175 | chr8:3567138-3567139 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs192091755 | chr8:3567141-3567142 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs9285038 | chr8:3567143-3567144 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs74824547 | chr8:3567171-3567172 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs534568341 | chr8:3567176-3567177 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs548526189 | chr8:3567191-3567192 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs200229033 | chr8:3567201-3567202 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs71534365 | chr8:3567202-3567203 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs77851270 | chr8:3567203-3567204 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs75091936 | chr8:3567204-3567205 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs62476969 | chr8:3567205-3567206 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs56272726 | chr8:3567231-3567232 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs368046204 | chr8:3567232-3567233 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs386721097 | chr8:3567235-3567236 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs10091302 | chr8:3567236-3567237 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:3563200-3569400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
2 | chr8:3566200-3567000 | Enhancers | Fetal Muscle Leg | muscle |